SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MECP2
|
ENSG00000169057.15 | methyl-CpG binding protein 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MECP2 | hg19_v2_chrX_-_153363188_153363212 | 0.48 | 3.1e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_42275153 | 7.03 |
ENST00000294964.5
|
PKDCC
|
protein kinase domain containing, cytoplasmic |
chr2_+_121103706 | 4.73 |
ENST00000295228.3
|
INHBB
|
inhibin, beta B |
chr16_+_770975 | 4.68 |
ENST00000569529.1
ENST00000564000.1 ENST00000219535.3 |
FAM173A
|
family with sequence similarity 173, member A |
chr12_-_117537240 | 4.67 |
ENST00000392545.4
ENST00000541210.1 ENST00000335209.7 |
TESC
|
tescalcin |
chr8_-_38325219 | 4.64 |
ENST00000533668.1
ENST00000413133.2 ENST00000397108.4 ENST00000526742.1 ENST00000525001.1 ENST00000425967.3 ENST00000529552.1 ENST00000397113.2 |
FGFR1
|
fibroblast growth factor receptor 1 |
chr19_+_589893 | 4.63 |
ENST00000251287.2
|
HCN2
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 2 |
chr19_+_35521572 | 4.61 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr16_+_1203194 | 4.49 |
ENST00000348261.5
ENST00000358590.4 |
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
chr19_+_33685490 | 4.47 |
ENST00000253193.7
|
LRP3
|
low density lipoprotein receptor-related protein 3 |
chr20_+_4129426 | 4.46 |
ENST00000339123.6
ENST00000305958.4 ENST00000278795.3 |
SMOX
|
spermine oxidase |
chr19_+_55795493 | 4.26 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
chr17_+_48638371 | 4.09 |
ENST00000360761.4
ENST00000352832.5 ENST00000354983.4 |
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit |
chr11_+_842928 | 4.00 |
ENST00000397408.1
|
TSPAN4
|
tetraspanin 4 |
chr5_+_175298573 | 3.95 |
ENST00000512824.1
|
CPLX2
|
complexin 2 |
chr19_+_16435625 | 3.73 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
chr11_+_842808 | 3.64 |
ENST00000397397.2
ENST00000397411.2 ENST00000397396.1 |
TSPAN4
|
tetraspanin 4 |
chr22_-_30970560 | 3.62 |
ENST00000402369.1
ENST00000406361.1 |
GAL3ST1
|
galactose-3-O-sulfotransferase 1 |
chr17_+_30593195 | 3.62 |
ENST00000431505.2
ENST00000269051.4 ENST00000538145.1 |
RHBDL3
|
rhomboid, veinlet-like 3 (Drosophila) |
chr1_-_935361 | 3.61 |
ENST00000484667.2
|
HES4
|
hes family bHLH transcription factor 4 |
chr1_+_33722080 | 3.59 |
ENST00000483388.1
ENST00000539719.1 |
ZNF362
|
zinc finger protein 362 |
chr20_+_4129496 | 3.53 |
ENST00000346595.2
|
SMOX
|
spermine oxidase |
chr9_-_138987115 | 3.47 |
ENST00000277554.2
|
NACC2
|
NACC family member 2, BEN and BTB (POZ) domain containing |
chr17_+_43299241 | 3.39 |
ENST00000328118.3
|
FMNL1
|
formin-like 1 |
chr4_+_2061119 | 3.38 |
ENST00000423729.2
|
NAT8L
|
N-acetyltransferase 8-like (GCN5-related, putative) |
chr17_-_3867585 | 3.33 |
ENST00000359983.3
ENST00000352011.3 ENST00000397043.3 ENST00000397041.3 ENST00000397035.3 ENST00000397039.1 ENST00000309890.7 |
ATP2A3
|
ATPase, Ca++ transporting, ubiquitous |
chr15_-_102029873 | 3.29 |
ENST00000348070.1
ENST00000358417.3 ENST00000344273.2 |
PCSK6
|
proprotein convertase subtilisin/kexin type 6 |
chr4_+_3768075 | 3.27 |
ENST00000509482.1
ENST00000330055.5 |
ADRA2C
|
adrenoceptor alpha 2C |
chr17_-_73761222 | 3.22 |
ENST00000437911.1
ENST00000225614.2 |
GALK1
|
galactokinase 1 |
chr9_+_139606983 | 3.17 |
ENST00000371692.4
|
FAM69B
|
family with sequence similarity 69, member B |
chr7_+_73082152 | 3.15 |
ENST00000324941.4
ENST00000451519.1 |
VPS37D
|
vacuolar protein sorting 37 homolog D (S. cerevisiae) |
chr21_+_46825032 | 3.15 |
ENST00000400337.2
|
COL18A1
|
collagen, type XVIII, alpha 1 |
chr11_+_57227981 | 3.13 |
ENST00000335099.3
|
RTN4RL2
|
reticulon 4 receptor-like 2 |
chr22_+_48972118 | 3.12 |
ENST00000358295.5
|
FAM19A5
|
family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 |
chr5_+_175298487 | 3.10 |
ENST00000393745.3
|
CPLX2
|
complexin 2 |
chr16_+_89642120 | 3.07 |
ENST00000268720.5
ENST00000319518.8 |
CPNE7
|
copine VII |
chr4_+_41362796 | 3.04 |
ENST00000508501.1
ENST00000512946.1 ENST00000313860.7 ENST00000512632.1 ENST00000512820.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr17_+_59477233 | 3.03 |
ENST00000240328.3
|
TBX2
|
T-box 2 |
chr14_+_105953204 | 3.02 |
ENST00000409393.2
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
chr19_+_35521616 | 2.97 |
ENST00000595652.1
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chrX_-_153775426 | 2.97 |
ENST00000393562.2
|
G6PD
|
glucose-6-phosphate dehydrogenase |
chr2_-_233792837 | 2.94 |
ENST00000373552.4
ENST00000409079.1 |
NGEF
|
neuronal guanine nucleotide exchange factor |
chr2_+_239756671 | 2.92 |
ENST00000448943.2
|
TWIST2
|
twist family bHLH transcription factor 2 |
chr11_+_849816 | 2.90 |
ENST00000527644.1
|
TSPAN4
|
tetraspanin 4 |
chr10_+_31608054 | 2.86 |
ENST00000320985.10
ENST00000361642.5 ENST00000560721.2 ENST00000558440.1 ENST00000424869.1 ENST00000542815.3 |
ZEB1
|
zinc finger E-box binding homeobox 1 |
chr20_+_388935 | 2.85 |
ENST00000382181.2
ENST00000400247.3 |
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1 |
chr7_+_2281843 | 2.84 |
ENST00000356714.1
ENST00000397049.1 |
NUDT1
|
nudix (nucleoside diphosphate linked moiety X)-type motif 1 |
chr4_+_150999418 | 2.84 |
ENST00000296550.7
|
DCLK2
|
doublecortin-like kinase 2 |
chr2_-_10220538 | 2.83 |
ENST00000381813.4
|
CYS1
|
cystin 1 |
chr9_+_139560197 | 2.82 |
ENST00000371698.3
|
EGFL7
|
EGF-like-domain, multiple 7 |
chr14_+_105957402 | 2.82 |
ENST00000421892.1
ENST00000334656.7 ENST00000451719.1 ENST00000392522.3 ENST00000392523.4 ENST00000354560.6 ENST00000450383.1 |
C14orf80
|
chromosome 14 open reading frame 80 |
chr15_+_27112058 | 2.81 |
ENST00000355395.5
|
GABRA5
|
gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
chr11_+_71934962 | 2.81 |
ENST00000543234.1
|
INPPL1
|
inositol polyphosphate phosphatase-like 1 |
chr9_+_137967268 | 2.79 |
ENST00000371799.4
ENST00000277415.11 |
OLFM1
|
olfactomedin 1 |
chr21_+_38071430 | 2.76 |
ENST00000290399.6
|
SIM2
|
single-minded family bHLH transcription factor 2 |
chr6_-_41909191 | 2.74 |
ENST00000512426.1
ENST00000372987.4 |
CCND3
|
cyclin D3 |
chr14_-_102026643 | 2.71 |
ENST00000555882.1
ENST00000554441.1 ENST00000553729.1 ENST00000557109.1 ENST00000557532.1 ENST00000554694.1 ENST00000554735.1 ENST00000555174.1 ENST00000557661.1 |
DIO3OS
|
DIO3 opposite strand/antisense RNA (head to head) |
chr6_+_1389989 | 2.71 |
ENST00000259806.1
|
FOXF2
|
forkhead box F2 |
chr12_+_3068466 | 2.70 |
ENST00000358409.2
|
TEAD4
|
TEA domain family member 4 |
chr3_-_129325660 | 2.70 |
ENST00000324093.4
ENST00000393239.1 |
PLXND1
|
plexin D1 |
chr15_-_71146460 | 2.70 |
ENST00000344870.4
|
LARP6
|
La ribonucleoprotein domain family, member 6 |
chr20_+_388791 | 2.69 |
ENST00000441733.1
ENST00000353660.3 |
RBCK1
|
RanBP-type and C3HC4-type zinc finger containing 1 |
chr2_+_10442993 | 2.68 |
ENST00000423674.1
ENST00000307845.3 |
HPCAL1
|
hippocalcin-like 1 |
chr12_+_52430894 | 2.66 |
ENST00000546842.1
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
chr9_+_130965651 | 2.66 |
ENST00000475805.1
ENST00000341179.7 ENST00000372923.3 |
DNM1
|
dynamin 1 |
chr2_+_20866424 | 2.65 |
ENST00000272224.3
|
GDF7
|
growth differentiation factor 7 |
chr14_+_105953246 | 2.64 |
ENST00000392531.3
|
CRIP1
|
cysteine-rich protein 1 (intestinal) |
chr5_+_175298674 | 2.61 |
ENST00000514150.1
|
CPLX2
|
complexin 2 |
chr4_+_2043689 | 2.61 |
ENST00000382878.3
ENST00000409248.4 |
C4orf48
|
chromosome 4 open reading frame 48 |
chr20_+_48807351 | 2.61 |
ENST00000303004.3
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta |
chr17_-_36105009 | 2.60 |
ENST00000560016.1
ENST00000427275.2 ENST00000561193.1 |
HNF1B
|
HNF1 homeobox B |
chr12_+_3068544 | 2.59 |
ENST00000540314.1
ENST00000536826.1 ENST00000359864.2 |
TEAD4
|
TEA domain family member 4 |
chr16_+_89894875 | 2.56 |
ENST00000393062.2
|
SPIRE2
|
spire-type actin nucleation factor 2 |
chr21_+_47518011 | 2.56 |
ENST00000300527.4
ENST00000357838.4 ENST00000310645.5 |
COL6A2
|
collagen, type VI, alpha 2 |
chr19_+_507299 | 2.54 |
ENST00000359315.5
|
TPGS1
|
tubulin polyglutamylase complex subunit 1 |
chr7_-_99869799 | 2.54 |
ENST00000436886.2
|
GATS
|
GATS, stromal antigen 3 opposite strand |
chr17_+_43299156 | 2.53 |
ENST00000331495.3
|
FMNL1
|
formin-like 1 |
chr8_-_38326139 | 2.53 |
ENST00000335922.5
ENST00000532791.1 ENST00000397091.5 |
FGFR1
|
fibroblast growth factor receptor 1 |
chr15_+_80696666 | 2.49 |
ENST00000303329.4
|
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2 |
chr16_-_74808710 | 2.48 |
ENST00000219368.3
ENST00000544337.1 |
FA2H
|
fatty acid 2-hydroxylase |
chr11_+_48002279 | 2.47 |
ENST00000534219.1
ENST00000527952.1 |
PTPRJ
|
protein tyrosine phosphatase, receptor type, J |
chr7_+_150756657 | 2.46 |
ENST00000413384.2
|
SLC4A2
|
solute carrier family 4 (anion exchanger), member 2 |
chr17_-_46724186 | 2.45 |
ENST00000433510.2
|
RP11-357H14.17
|
RP11-357H14.17 |
chr4_+_2043777 | 2.44 |
ENST00000409860.1
|
C4orf48
|
chromosome 4 open reading frame 48 |
chr19_-_46272106 | 2.44 |
ENST00000560168.1
|
SIX5
|
SIX homeobox 5 |
chr20_-_60942361 | 2.44 |
ENST00000252999.3
|
LAMA5
|
laminin, alpha 5 |
chr8_-_21988558 | 2.44 |
ENST00000312841.8
|
HR
|
hair growth associated |
chr3_-_13461807 | 2.43 |
ENST00000254508.5
|
NUP210
|
nucleoporin 210kDa |
chr19_-_33793430 | 2.42 |
ENST00000498907.2
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha |
chr2_-_239148599 | 2.40 |
ENST00000409182.1
ENST00000409002.3 ENST00000450098.1 ENST00000409356.1 ENST00000409160.3 ENST00000409574.1 ENST00000272937.5 |
HES6
|
hes family bHLH transcription factor 6 |
chr9_+_137967366 | 2.40 |
ENST00000252854.4
|
OLFM1
|
olfactomedin 1 |
chr13_-_114103443 | 2.38 |
ENST00000356501.4
ENST00000413169.2 |
ADPRHL1
|
ADP-ribosylhydrolase like 1 |
chr17_+_73083816 | 2.38 |
ENST00000580123.1
ENST00000578847.1 |
SLC16A5
|
solute carrier family 16 (monocarboxylate transporter), member 5 |
chr18_+_8705588 | 2.37 |
ENST00000306329.11
|
SOGA2
|
SOGA family member 2 |
chr2_+_202899310 | 2.37 |
ENST00000286201.1
|
FZD7
|
frizzled family receptor 7 |
chr9_-_139581848 | 2.36 |
ENST00000538402.1
ENST00000371694.3 |
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
chr16_-_17564738 | 2.36 |
ENST00000261381.6
|
XYLT1
|
xylosyltransferase I |
chr19_-_47922750 | 2.36 |
ENST00000331559.5
|
MEIS3
|
Meis homeobox 3 |
chr15_-_77924689 | 2.36 |
ENST00000355300.6
|
LINGO1
|
leucine rich repeat and Ig domain containing 1 |
chr14_-_102976135 | 2.34 |
ENST00000560748.1
|
ANKRD9
|
ankyrin repeat domain 9 |
chr19_-_56632592 | 2.34 |
ENST00000587279.1
ENST00000270459.3 |
ZNF787
|
zinc finger protein 787 |
chr19_+_35521699 | 2.33 |
ENST00000415950.3
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr17_+_19437132 | 2.33 |
ENST00000436810.2
ENST00000270570.4 ENST00000457293.1 ENST00000542886.1 ENST00000575023.1 ENST00000395585.1 |
SLC47A1
|
solute carrier family 47 (multidrug and toxin extrusion), member 1 |
chr17_-_78450398 | 2.33 |
ENST00000306773.4
|
NPTX1
|
neuronal pentraxin I |
chr5_+_176873789 | 2.32 |
ENST00000323249.3
ENST00000502922.1 |
PRR7
|
proline rich 7 (synaptic) |
chr19_-_38746979 | 2.32 |
ENST00000591291.1
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
chr2_-_175202151 | 2.31 |
ENST00000595354.1
|
AC018470.1
|
Uncharacterized protein FLJ46347 |
chr11_-_615942 | 2.31 |
ENST00000397562.3
ENST00000330243.5 ENST00000397570.1 ENST00000397574.2 |
IRF7
|
interferon regulatory factor 7 |
chr2_+_239067597 | 2.31 |
ENST00000546354.1
|
FAM132B
|
family with sequence similarity 132, member B |
chr3_-_129035120 | 2.31 |
ENST00000333762.4
|
H1FX
|
H1 histone family, member X |
chr16_-_3030407 | 2.30 |
ENST00000431515.2
ENST00000574385.1 ENST00000576268.1 ENST00000574730.1 ENST00000575632.1 ENST00000573944.1 ENST00000262300.8 |
PKMYT1
|
protein kinase, membrane associated tyrosine/threonine 1 |
chr12_-_58026426 | 2.29 |
ENST00000418555.2
|
B4GALNT1
|
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
chr6_+_7727030 | 2.29 |
ENST00000283147.6
|
BMP6
|
bone morphogenetic protein 6 |
chr20_+_57267669 | 2.29 |
ENST00000356091.6
|
NPEPL1
|
aminopeptidase-like 1 |
chr15_+_27112251 | 2.28 |
ENST00000400081.3
|
GABRA5
|
gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
chr9_-_33264557 | 2.28 |
ENST00000473781.1
ENST00000488499.1 |
BAG1
|
BCL2-associated athanogene |
chr20_-_4804244 | 2.27 |
ENST00000379400.3
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2 |
chr19_+_34287174 | 2.27 |
ENST00000587559.1
ENST00000588637.1 |
KCTD15
|
potassium channel tetramerization domain containing 15 |
chr14_-_21566731 | 2.26 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
chr19_+_34745442 | 2.26 |
ENST00000299505.6
ENST00000588470.1 ENST00000589583.1 ENST00000588338.2 |
KIAA0355
|
KIAA0355 |
chr17_-_79519403 | 2.26 |
ENST00000327787.8
ENST00000537152.1 |
C17orf70
|
chromosome 17 open reading frame 70 |
chr11_+_61560348 | 2.25 |
ENST00000535723.1
ENST00000574708.1 |
FEN1
FADS2
|
flap structure-specific endonuclease 1 fatty acid desaturase 2 |
chr12_+_47473369 | 2.24 |
ENST00000546455.1
|
PCED1B
|
PC-esterase domain containing 1B |
chr5_+_176513895 | 2.23 |
ENST00000503708.1
ENST00000393648.2 ENST00000514472.1 ENST00000502906.1 ENST00000292410.3 ENST00000510911.1 |
FGFR4
|
fibroblast growth factor receptor 4 |
chr1_-_935491 | 2.21 |
ENST00000304952.6
|
HES4
|
hes family bHLH transcription factor 4 |
chr11_+_44748361 | 2.21 |
ENST00000533202.1
ENST00000533080.1 ENST00000520358.2 ENST00000520999.2 |
TSPAN18
|
tetraspanin 18 |
chr2_-_225907150 | 2.20 |
ENST00000258390.7
|
DOCK10
|
dedicator of cytokinesis 10 |
chr19_-_18391708 | 2.20 |
ENST00000600972.1
|
JUND
|
jun D proto-oncogene |
chr2_+_8822113 | 2.19 |
ENST00000396290.1
ENST00000331129.3 |
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
chr5_+_149865377 | 2.19 |
ENST00000522491.1
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
chr12_+_20522179 | 2.18 |
ENST00000359062.3
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited |
chr20_+_42295745 | 2.17 |
ENST00000396863.4
ENST00000217026.4 |
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
chr20_+_361890 | 2.16 |
ENST00000449710.1
ENST00000422053.2 |
TRIB3
|
tribbles pseudokinase 3 |
chr19_+_36120009 | 2.15 |
ENST00000589871.1
|
RBM42
|
RNA binding motif protein 42 |
chr16_+_2039946 | 2.15 |
ENST00000248121.2
ENST00000568896.1 |
SYNGR3
|
synaptogyrin 3 |
chr16_-_2097787 | 2.15 |
ENST00000566380.1
ENST00000219066.1 |
NTHL1
|
nth endonuclease III-like 1 (E. coli) |
chr19_-_38747172 | 2.15 |
ENST00000347262.4
ENST00000591585.1 ENST00000301242.4 |
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
chr16_+_577697 | 2.15 |
ENST00000562370.1
ENST00000568988.1 ENST00000219611.2 |
CAPN15
|
calpain 15 |
chr8_-_38326119 | 2.15 |
ENST00000356207.5
ENST00000326324.6 |
FGFR1
|
fibroblast growth factor receptor 1 |
chr9_-_133814455 | 2.14 |
ENST00000448616.1
|
FIBCD1
|
fibrinogen C domain containing 1 |
chr11_-_615570 | 2.14 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
chr14_+_105559784 | 2.14 |
ENST00000548104.1
|
RP11-44N21.1
|
RP11-44N21.1 |
chr15_+_66994561 | 2.14 |
ENST00000288840.5
|
SMAD6
|
SMAD family member 6 |
chr7_+_2281882 | 2.14 |
ENST00000397046.1
ENST00000397048.1 ENST00000454650.1 |
NUDT1
|
nudix (nucleoside diphosphate linked moiety X)-type motif 1 |
chr10_+_134210672 | 2.12 |
ENST00000305233.5
ENST00000368609.4 |
PWWP2B
|
PWWP domain containing 2B |
chr6_+_160769399 | 2.11 |
ENST00000392145.1
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3 |
chr17_+_5973793 | 2.11 |
ENST00000317744.5
|
WSCD1
|
WSC domain containing 1 |
chr14_-_77495007 | 2.11 |
ENST00000238647.3
|
IRF2BPL
|
interferon regulatory factor 2 binding protein-like |
chr17_+_64961026 | 2.10 |
ENST00000262138.3
|
CACNG4
|
calcium channel, voltage-dependent, gamma subunit 4 |
chr5_-_132166303 | 2.10 |
ENST00000440118.1
|
SHROOM1
|
shroom family member 1 |
chr17_+_64298944 | 2.10 |
ENST00000413366.3
|
PRKCA
|
protein kinase C, alpha |
chr5_-_1295104 | 2.09 |
ENST00000334602.6
ENST00000508104.2 ENST00000310581.5 ENST00000296820.5 |
TERT
|
telomerase reverse transcriptase |
chr6_+_160769300 | 2.09 |
ENST00000275300.2
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3 |
chr10_+_28966271 | 2.09 |
ENST00000375533.3
|
BAMBI
|
BMP and activin membrane-bound inhibitor |
chr3_+_127391769 | 2.08 |
ENST00000393363.3
ENST00000232744.8 ENST00000453791.2 |
ABTB1
|
ankyrin repeat and BTB (POZ) domain containing 1 |
chr9_+_97767235 | 2.08 |
ENST00000445181.1
|
C9orf3
|
chromosome 9 open reading frame 3 |
chr20_+_35974532 | 2.07 |
ENST00000373578.2
|
SRC
|
v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog |
chr19_+_14544099 | 2.07 |
ENST00000242783.6
ENST00000586557.1 ENST00000590097.1 |
PKN1
|
protein kinase N1 |
chr11_-_64851496 | 2.07 |
ENST00000404147.3
ENST00000275517.3 |
CDCA5
|
cell division cycle associated 5 |
chr8_-_145754428 | 2.07 |
ENST00000527462.1
ENST00000313465.5 ENST00000524821.1 |
C8orf82
|
chromosome 8 open reading frame 82 |
chr7_+_129142320 | 2.06 |
ENST00000462322.2
|
SMKR1
|
small lysine-rich protein 1 |
chr20_-_61885826 | 2.06 |
ENST00000370316.3
|
NKAIN4
|
Na+/K+ transporting ATPase interacting 4 |
chr9_+_130965677 | 2.06 |
ENST00000393594.3
ENST00000486160.1 |
DNM1
|
dynamin 1 |
chr20_-_62129163 | 2.06 |
ENST00000298049.7
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
chr17_+_60704762 | 2.04 |
ENST00000303375.5
|
MRC2
|
mannose receptor, C type 2 |
chr17_+_77751931 | 2.04 |
ENST00000310942.4
ENST00000269399.5 |
CBX2
|
chromobox homolog 2 |
chr20_+_2673383 | 2.04 |
ENST00000380648.4
ENST00000342725.5 |
EBF4
|
early B-cell factor 4 |
chr2_+_130939827 | 2.04 |
ENST00000409255.1
ENST00000455239.1 |
MZT2B
|
mitotic spindle organizing protein 2B |
chr9_-_133814527 | 2.03 |
ENST00000451466.1
|
FIBCD1
|
fibrinogen C domain containing 1 |
chr15_+_66994663 | 2.02 |
ENST00000457357.2
|
SMAD6
|
SMAD family member 6 |
chr22_-_39239987 | 2.01 |
ENST00000333039.2
|
NPTXR
|
neuronal pentraxin receptor |
chr17_+_78194205 | 2.01 |
ENST00000573809.1
ENST00000361193.3 ENST00000574967.1 ENST00000576126.1 ENST00000411502.3 ENST00000546047.2 |
SLC26A11
|
solute carrier family 26 (anion exchanger), member 11 |
chr19_-_39466396 | 1.99 |
ENST00000292852.4
|
FBXO17
|
F-box protein 17 |
chr16_+_699319 | 1.98 |
ENST00000549091.1
ENST00000293879.4 |
WDR90
|
WD repeat domain 90 |
chr19_-_47551836 | 1.98 |
ENST00000253047.6
|
TMEM160
|
transmembrane protein 160 |
chr3_-_5229982 | 1.98 |
ENST00000600805.1
|
AC026202.1
|
Uncharacterized protein |
chr12_+_54332535 | 1.97 |
ENST00000243056.3
|
HOXC13
|
homeobox C13 |
chrX_-_153707545 | 1.97 |
ENST00000357360.4
|
LAGE3
|
L antigen family, member 3 |
chr9_+_135037334 | 1.96 |
ENST00000393229.3
ENST00000360670.3 ENST00000393228.4 ENST00000372179.3 |
NTNG2
|
netrin G2 |
chr6_-_42858534 | 1.95 |
ENST00000408925.2
|
C6orf226
|
chromosome 6 open reading frame 226 |
chr9_-_139581875 | 1.95 |
ENST00000371696.2
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
chr2_-_127864839 | 1.95 |
ENST00000409400.1
ENST00000357970.3 ENST00000393040.3 ENST00000348750.4 ENST00000259238.4 ENST00000346226.3 ENST00000393041.3 ENST00000351659.3 ENST00000352848.3 ENST00000316724.5 |
BIN1
|
bridging integrator 1 |
chr22_+_18893736 | 1.95 |
ENST00000331444.6
|
DGCR6
|
DiGeorge syndrome critical region gene 6 |
chr22_-_37415475 | 1.94 |
ENST00000403892.3
ENST00000249042.3 ENST00000438203.1 |
TST
|
thiosulfate sulfurtransferase (rhodanese) |
chr11_+_8102846 | 1.93 |
ENST00000299506.2
|
TUB
|
tubby bipartite transcription factor |
chr8_+_145137489 | 1.91 |
ENST00000355091.4
ENST00000525087.1 ENST00000361036.6 ENST00000524418.1 |
GPAA1
|
glycosylphosphatidylinositol anchor attachment 1 |
chr8_+_31497271 | 1.90 |
ENST00000520407.1
|
NRG1
|
neuregulin 1 |
chr12_-_47473642 | 1.89 |
ENST00000266581.4
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
chr12_+_7023491 | 1.88 |
ENST00000541477.1
ENST00000229277.1 |
ENO2
|
enolase 2 (gamma, neuronal) |
chr11_+_61520075 | 1.88 |
ENST00000278836.5
|
MYRF
|
myelin regulatory factor |
chr10_-_134121438 | 1.86 |
ENST00000298630.3
|
STK32C
|
serine/threonine kinase 32C |
chr21_-_45759250 | 1.85 |
ENST00000397956.3
ENST00000339818.4 ENST00000325223.7 |
C21orf2
|
chromosome 21 open reading frame 2 |
chr12_-_58131931 | 1.85 |
ENST00000547588.1
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
chr17_+_34958001 | 1.85 |
ENST00000250156.7
|
MRM1
|
mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae) |
chr16_-_88717482 | 1.85 |
ENST00000261623.3
|
CYBA
|
cytochrome b-245, alpha polypeptide |
chr10_+_101089107 | 1.84 |
ENST00000446890.1
ENST00000370528.3 |
CNNM1
|
cyclin M1 |
chr7_-_134855402 | 1.84 |
ENST00000424142.1
ENST00000483029.2 ENST00000393114.3 |
C7orf49
|
chromosome 7 open reading frame 49 |
chr10_+_47083454 | 1.84 |
ENST00000374312.1
|
NPY4R
|
neuropeptide Y receptor Y4 |
chr19_+_36119929 | 1.84 |
ENST00000588161.1
ENST00000262633.4 ENST00000592202.1 ENST00000586618.1 |
RBM42
|
RNA binding motif protein 42 |
chr12_+_132312931 | 1.84 |
ENST00000360564.1
ENST00000545671.1 ENST00000545790.1 |
MMP17
|
matrix metallopeptidase 17 (membrane-inserted) |
chr19_+_49622646 | 1.84 |
ENST00000334186.4
|
PPFIA3
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.3 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
2.5 | 9.9 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
1.6 | 4.7 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
1.4 | 1.4 | GO:1990403 | embryonic brain development(GO:1990403) |
1.4 | 6.8 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
1.3 | 3.9 | GO:0090427 | activation of meiosis(GO:0090427) |
1.3 | 6.3 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.2 | 7.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.2 | 1.2 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
1.2 | 8.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.1 | 3.4 | GO:1901207 | regulation of heart looping(GO:1901207) |
1.1 | 4.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.1 | 6.5 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.1 | 3.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.0 | 4.1 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
1.0 | 9.8 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.0 | 2.9 | GO:0043181 | vacuolar sequestering(GO:0043181) |
1.0 | 5.8 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.9 | 4.6 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.9 | 0.9 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
0.9 | 0.9 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) positive regulation of endothelial cell differentiation(GO:0045603) |
0.9 | 3.6 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.9 | 4.4 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.9 | 0.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.9 | 3.4 | GO:0039020 | pronephric nephron tubule development(GO:0039020) |
0.8 | 2.5 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
0.8 | 2.5 | GO:0034226 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
0.8 | 1.6 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.8 | 4.9 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.8 | 4.0 | GO:0032218 | riboflavin transport(GO:0032218) |
0.8 | 3.2 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.8 | 0.8 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
0.8 | 2.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.8 | 3.2 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.8 | 1.5 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.8 | 3.1 | GO:0032811 | regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epinephrine secretion(GO:0048242) |
0.8 | 1.5 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.7 | 4.4 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.7 | 2.9 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.7 | 5.1 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.7 | 0.7 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.7 | 2.2 | GO:1902356 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.7 | 1.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.7 | 2.1 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.7 | 7.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.7 | 2.8 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.7 | 2.0 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.7 | 2.0 | GO:0097187 | dentinogenesis(GO:0097187) |
0.7 | 0.7 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.7 | 2.7 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.7 | 3.3 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.7 | 1.3 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.7 | 4.0 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
0.7 | 0.7 | GO:0060214 | endocardium formation(GO:0060214) |
0.7 | 2.0 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.7 | 2.0 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.7 | 2.0 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.7 | 2.6 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.6 | 1.9 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.6 | 3.2 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.6 | 3.2 | GO:1903412 | response to bile acid(GO:1903412) |
0.6 | 5.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.6 | 6.4 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.6 | 5.0 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.6 | 8.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.6 | 4.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.6 | 5.6 | GO:0046618 | drug export(GO:0046618) |
0.6 | 2.4 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.6 | 1.8 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
0.6 | 2.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.6 | 1.8 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.6 | 4.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.6 | 0.6 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.6 | 7.4 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.6 | 6.8 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.6 | 0.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.6 | 2.8 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.5 | 2.7 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.5 | 1.6 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
0.5 | 9.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.5 | 1.6 | GO:0003168 | Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
0.5 | 2.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.5 | 1.6 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.5 | 6.8 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.5 | 4.2 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.5 | 1.6 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
0.5 | 1.6 | GO:0061743 | motor learning(GO:0061743) maintenance of synapse structure(GO:0099558) |
0.5 | 2.1 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.5 | 1.5 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.5 | 1.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.5 | 3.5 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.5 | 4.5 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.5 | 4.0 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.5 | 3.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.5 | 3.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.5 | 0.5 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
0.5 | 1.5 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
0.5 | 2.9 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.5 | 2.4 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.5 | 2.9 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.5 | 1.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.5 | 1.9 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.5 | 2.4 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.5 | 2.4 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.5 | 0.5 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.5 | 0.5 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.5 | 1.8 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.5 | 1.4 | GO:0015882 | L-ascorbic acid transport(GO:0015882) molecular hydrogen transport(GO:0015993) transepithelial L-ascorbic acid transport(GO:0070904) |
0.5 | 9.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.5 | 0.9 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.4 | 2.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.4 | 12.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.4 | 1.8 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.4 | 1.3 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.4 | 1.3 | GO:1902203 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
0.4 | 4.4 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.4 | 1.7 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.4 | 1.3 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.4 | 1.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.4 | 0.4 | GO:0061549 | sympathetic ganglion development(GO:0061549) |
0.4 | 3.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.4 | 4.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.4 | 0.8 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.4 | 1.3 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
0.4 | 1.7 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.4 | 2.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.4 | 1.2 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.4 | 1.6 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.4 | 0.8 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.4 | 1.6 | GO:0060032 | notochord regression(GO:0060032) |
0.4 | 1.6 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.4 | 2.8 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.4 | 5.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.4 | 1.2 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.4 | 1.6 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.4 | 2.7 | GO:0030200 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.4 | 1.9 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.4 | 5.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.4 | 1.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.4 | 1.1 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.4 | 1.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.4 | 1.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 1.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.4 | 1.5 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.4 | 1.1 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.4 | 0.7 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.4 | 2.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.4 | 0.7 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.4 | 0.7 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
0.4 | 1.1 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.4 | 0.7 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.4 | 1.5 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.4 | 2.9 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.4 | 1.1 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.4 | 1.1 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.4 | 2.1 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.4 | 2.5 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.4 | 0.4 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 1.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.4 | 2.1 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.4 | 3.2 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.4 | 1.1 | GO:1903217 | regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
0.3 | 1.4 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.3 | 1.7 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.3 | 2.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 1.4 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.3 | 4.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 0.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.3 | 0.3 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.3 | 1.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.3 | 0.3 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.3 | 1.0 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.3 | 1.0 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.3 | 0.7 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.3 | 1.7 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.3 | 0.7 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.3 | 0.7 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.3 | 0.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.3 | 0.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.3 | 0.7 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.3 | 1.0 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.3 | 0.7 | GO:0006272 | leading strand elongation(GO:0006272) |
0.3 | 13.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.3 | 0.7 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
0.3 | 1.6 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 1.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 1.3 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.3 | 1.9 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
0.3 | 1.0 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.3 | 3.5 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.3 | 1.9 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 2.5 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.3 | 0.6 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.3 | 5.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 1.2 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.3 | 0.9 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.3 | 1.2 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
0.3 | 0.9 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.3 | 0.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 0.9 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.3 | 0.3 | GO:0048370 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) |
0.3 | 0.6 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.3 | 1.2 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 1.5 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.3 | 0.9 | GO:2000627 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
0.3 | 2.7 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.3 | 0.9 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.3 | 0.6 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.3 | 0.9 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.3 | 3.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.3 | 0.6 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.3 | 1.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.3 | 1.2 | GO:0042262 | DNA protection(GO:0042262) |
0.3 | 0.9 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 0.9 | GO:0061312 | BMP signaling pathway involved in heart development(GO:0061312) |
0.3 | 3.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 1.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 1.1 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.3 | 2.0 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.3 | 0.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 1.1 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.3 | 0.9 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
0.3 | 2.0 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.3 | 0.9 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.3 | 2.0 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.3 | 0.6 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 0.9 | GO:0035566 | vestibulocochlear nerve formation(GO:0021650) regulation of metanephros size(GO:0035566) |
0.3 | 2.6 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.3 | 0.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 1.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.3 | 6.5 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.3 | 2.3 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.3 | 1.1 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.3 | 7.3 | GO:0031167 | rRNA methylation(GO:0031167) |
0.3 | 0.3 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.3 | 3.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.3 | 0.3 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
0.3 | 0.3 | GO:0072218 | ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
0.3 | 1.1 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.3 | 0.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 1.1 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.3 | 1.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 1.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 1.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.3 | 0.8 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.3 | 0.5 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.3 | 2.7 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.3 | 0.8 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.3 | 0.5 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 0.8 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
0.3 | 0.8 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.3 | 0.3 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.3 | 1.1 | GO:0060995 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.3 | 0.8 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
0.3 | 1.3 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.3 | 1.1 | GO:0002432 | granuloma formation(GO:0002432) |
0.3 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 1.3 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine diphosphate metabolic process(GO:0042357) |
0.3 | 0.5 | GO:0003285 | septum secundum development(GO:0003285) |
0.3 | 1.0 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.3 | 1.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.3 | 0.3 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) |
0.3 | 0.3 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.3 | 0.3 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.3 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.3 | 1.3 | GO:1902228 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.3 | 0.8 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.3 | 0.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.3 | 1.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 1.0 | GO:1900148 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.3 | 1.0 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.3 | 0.8 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.3 | 3.3 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.3 | 2.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.3 | 1.0 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
0.3 | 2.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 5.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 2.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 0.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 6.0 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.2 | 1.7 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.7 | GO:0060829 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.2 | 0.7 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.2 | 2.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.2 | 0.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.5 | GO:0035712 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
0.2 | 2.5 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.2 | 0.7 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 0.2 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
0.2 | 1.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 3.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 5.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 3.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 1.0 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 1.0 | GO:1904106 | protein localization to microvillus(GO:1904106) |
0.2 | 2.7 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 0.7 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.2 | 0.7 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 0.2 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
0.2 | 4.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.5 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.2 | 2.1 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.2 | 1.9 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.2 | 0.7 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.2 | 0.5 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.2 | 1.9 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.2 | 2.1 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.2 | 1.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.2 | 0.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 2.5 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 4.4 | GO:0019532 | oxalate transport(GO:0019532) |
0.2 | 0.5 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.2 | 1.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 1.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 1.1 | GO:0051292 | nuclear pore organization(GO:0006999) nuclear pore complex assembly(GO:0051292) |
0.2 | 0.7 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
0.2 | 4.3 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 1.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 2.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 0.7 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.2 | 1.3 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.2 | 6.0 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 2.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.2 | 1.1 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.2 | 0.7 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) |
0.2 | 2.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 3.3 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.2 | 1.1 | GO:0000436 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
0.2 | 1.3 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.2 | 0.6 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.2 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 0.9 | GO:0008355 | olfactory learning(GO:0008355) |
0.2 | 3.6 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.2 | 0.4 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.2 | 1.5 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.2 | 0.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.2 | 3.0 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 0.2 | GO:0001759 | organ induction(GO:0001759) embryonic skeletal joint development(GO:0072498) |
0.2 | 0.4 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.2 | 0.4 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 3.6 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 0.4 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.2 | 1.5 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.4 | GO:0043132 | NAD transport(GO:0043132) |
0.2 | 0.2 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.2 | 0.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 0.6 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 1.8 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 1.2 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.2 | 1.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 1.0 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.2 | 1.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.2 | 0.6 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
0.2 | 1.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.2 | 1.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.2 | 0.8 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.2 | 1.2 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.2 | 0.8 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.2 | 0.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.8 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.2 | 0.2 | GO:0060928 | cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
0.2 | 2.1 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.2 | 2.7 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 0.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.2 | 1.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.4 | GO:0033590 | response to cobalamin(GO:0033590) |
0.2 | 0.8 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.4 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
0.2 | 0.6 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 0.8 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
0.2 | 1.7 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 0.9 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.2 | 0.9 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.6 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.2 | 0.7 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.2 | 1.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 4.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 1.3 | GO:0071486 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.2 | 1.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.2 | 0.4 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.2 | 0.7 | GO:0015819 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
0.2 | 0.7 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.2 | 1.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 0.4 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.2 | 2.0 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.2 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.2 | 0.7 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.2 | 0.9 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.2 | 0.9 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.2 | 0.5 | GO:0097360 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) Spemann organizer formation(GO:0060061) chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.2 | 1.8 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.2 | 0.2 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.2 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.2 | 1.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 0.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 1.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 1.6 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.9 | GO:0051414 | response to cortisol(GO:0051414) apoptotic process involved in luteolysis(GO:0061364) |
0.2 | 0.7 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 2.5 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.7 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.2 | 0.5 | GO:0046203 | spermidine catabolic process(GO:0046203) |
0.2 | 0.5 | GO:0018011 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.2 | 0.7 | GO:0003016 | respiratory system process(GO:0003016) |
0.2 | 0.9 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.7 | GO:0046884 | regulation of follicle-stimulating hormone secretion(GO:0046880) positive regulation of follicle-stimulating hormone secretion(GO:0046881) follicle-stimulating hormone secretion(GO:0046884) |
0.2 | 0.3 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.2 | 4.8 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.2 | 1.2 | GO:0019075 | virus maturation(GO:0019075) |
0.2 | 2.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 1.9 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 1.0 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.2 | 0.9 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 1.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 0.7 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.2 | 1.4 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.2 | 3.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.2 | 0.5 | GO:0019516 | lactate oxidation(GO:0019516) |
0.2 | 0.5 | GO:0032827 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
0.2 | 0.2 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
0.2 | 1.5 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.2 | 2.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.7 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.2 | 3.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.5 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.2 | 0.3 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.2 | 1.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 1.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.2 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.2 | 8.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 2.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 1.0 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.2 | 0.5 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.2 | 1.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 2.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 2.5 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 0.3 | GO:0002118 | aggressive behavior(GO:0002118) |
0.2 | 0.5 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.2 | 5.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.2 | GO:1990709 | presynaptic active zone organization(GO:1990709) |
0.2 | 1.5 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.2 | 3.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 1.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 1.1 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
0.2 | 3.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.8 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 1.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.2 | 0.2 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.2 | 0.6 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.2 | 0.5 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.2 | 1.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.2 | GO:0072197 | retinal rod cell differentiation(GO:0060221) ureter morphogenesis(GO:0072197) |
0.2 | 0.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 2.7 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.2 | 0.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 1.1 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.2 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 2.8 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 0.3 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.2 | 4.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 0.9 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 0.3 | GO:0051958 | methotrexate transport(GO:0051958) |
0.2 | 0.3 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.2 | 0.6 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.2 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.3 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 1.7 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 5.0 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.2 | 0.6 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.2 | 2.0 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 3.0 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.2 | 0.5 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 0.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.2 | 0.3 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.2 | 0.2 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 1.2 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.3 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 0.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 2.1 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 1.8 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.3 | GO:0060197 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.1 | 2.7 | GO:0009757 | hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.1 | 0.4 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.1 | 0.3 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
0.1 | 0.4 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.4 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 1.9 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.3 | GO:0070256 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.1 | 2.1 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.1 | GO:0009145 | purine nucleoside triphosphate biosynthetic process(GO:0009145) |
0.1 | 1.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 5.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.3 | GO:0099565 | chemical synaptic transmission, postsynaptic(GO:0099565) |
0.1 | 1.9 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.4 | GO:0060345 | spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.1 | 2.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.3 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.1 | 2.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.7 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.1 | 2.3 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.4 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.1 | 0.3 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.1 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 0.4 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 1.9 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.4 | GO:1902568 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.1 | 3.6 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.7 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.1 | 0.4 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.1 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.3 | GO:0044533 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.1 | 0.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.3 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 1.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 2.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.3 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.1 | 0.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.8 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 1.2 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 1.1 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.1 | 2.3 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 1.8 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 1.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.4 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
0.1 | 1.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.4 | GO:0072014 | proximal tubule development(GO:0072014) |
0.1 | 0.4 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.1 | 0.4 | GO:0030821 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
0.1 | 0.4 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 2.2 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.9 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.7 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.1 | 0.4 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 0.4 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.1 | 0.5 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.1 | 0.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 2.7 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 0.4 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.1 | 0.7 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 2.9 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.4 | GO:0061217 | regulation of mesonephros development(GO:0061217) |
0.1 | 0.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 1.0 | GO:0050893 | sensory processing(GO:0050893) |
0.1 | 0.3 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.3 | GO:0030647 | glycoside metabolic process(GO:0016137) polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.8 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.1 | 0.6 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.6 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.1 | 0.5 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) |
0.1 | 2.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 2.6 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 1.9 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 0.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 1.7 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.1 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
0.1 | 0.6 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.5 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 | 1.5 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.1 | 0.6 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.1 | 0.5 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.1 | 0.9 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.1 | 0.4 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.1 | GO:0035549 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
0.1 | 0.9 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.1 | 1.0 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 1.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 1.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 1.7 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.1 | 0.6 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 2.5 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 1.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 1.3 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.2 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.1 | 0.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 1.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.6 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
0.1 | 0.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.5 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.4 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.1 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.9 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 1.1 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.2 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.1 | 0.1 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.1 | 1.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.2 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 1.0 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.1 | 1.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 1.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.5 | GO:0045208 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
0.1 | 0.7 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.4 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.1 | 0.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.6 | GO:1901073 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
0.1 | 0.5 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.1 | 0.2 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.1 | 0.9 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.9 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.7 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 2.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 2.1 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.1 | 2.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.6 | GO:0019303 | D-ribose metabolic process(GO:0006014) D-ribose catabolic process(GO:0019303) |
0.1 | 0.2 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 0.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 2.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.5 | GO:0044211 | CTP salvage(GO:0044211) |
0.1 | 2.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.9 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.9 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 4.9 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.1 | 1.7 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.1 | 0.2 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.1 | 0.9 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 1.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.1 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.8 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.1 | 1.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.7 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.1 | 1.2 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.3 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
0.1 | 1.6 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.7 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.9 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.1 | GO:0072179 | nephric duct formation(GO:0072179) |
0.1 | 1.1 | GO:0097338 | response to clozapine(GO:0097338) |
0.1 | 0.1 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.1 | 0.7 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.1 | 1.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.4 | GO:0035624 | receptor transactivation(GO:0035624) |
0.1 | 0.1 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
0.1 | 0.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.1 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.1 | 0.4 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.2 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.1 | 0.7 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.8 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 0.2 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.3 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.1 | 3.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.4 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.1 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.8 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 0.4 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.1 | 0.2 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.1 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
0.1 | 0.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.4 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.1 | 2.4 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.5 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.1 | 0.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 11.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.1 | 0.4 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.1 | 0.4 | GO:1990523 | bone regeneration(GO:1990523) |
0.1 | 1.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.3 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.1 | 1.1 | GO:0098659 | sodium ion import(GO:0097369) inorganic cation import into cell(GO:0098659) sodium ion import across plasma membrane(GO:0098719) inorganic ion import into cell(GO:0099587) sodium ion import into cell(GO:1990118) |
0.1 | 0.5 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.4 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.2 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) peptidyl-glutamic acid modification(GO:0018200) protein carboxylation(GO:0018214) |
0.1 | 0.9 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:1901420 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
0.1 | 0.1 | GO:0046619 | optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
0.1 | 3.0 | GO:0071173 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.1 | 1.3 | GO:0072311 | glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 0.3 | GO:0021997 | neural plate axis specification(GO:0021997) |
0.1 | 0.7 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 3.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.8 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.6 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.1 | 0.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.3 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.1 | 0.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.5 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.1 | 0.7 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
0.1 | 0.8 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 2.5 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 1.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.1 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.1 | 0.4 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.1 | 0.1 | GO:0071469 | response to alkaline pH(GO:0010446) cellular response to alkaline pH(GO:0071469) |
0.1 | 0.5 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.1 | 1.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.1 | 0.5 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.1 | 0.6 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.1 | 0.4 | GO:0016598 | protein arginylation(GO:0016598) |
0.1 | 1.1 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.1 | 0.5 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 1.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.5 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.1 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 1.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.4 | GO:0086017 | Purkinje myocyte action potential(GO:0086017) membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.1 | 3.8 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 3.0 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.1 | 1.1 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.3 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.5 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 1.3 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.1 | 1.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.2 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.1 | 0.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.8 | GO:0015827 | tryptophan transport(GO:0015827) |
0.1 | 5.8 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 2.1 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 3.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.3 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
0.1 | 0.9 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.1 | 1.1 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 0.7 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.1 | 0.2 | GO:0032096 | regulation of response to food(GO:0032095) negative regulation of response to food(GO:0032096) regulation of appetite(GO:0032098) negative regulation of appetite(GO:0032099) |
0.1 | 0.9 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 1.2 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
0.1 | 1.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 1.0 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 0.7 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.1 | 0.2 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) regulation of DNA ligase activity(GO:1904875) |
0.1 | 0.8 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 1.4 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 2.5 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.8 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.1 | 0.3 | GO:0070943 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
0.1 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 6.1 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
0.1 | 0.2 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.1 | 1.0 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 0.7 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 4.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 3.3 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 1.7 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 0.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 1.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.1 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.1 | 0.2 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.7 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.2 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.4 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.4 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
0.1 | 0.2 | GO:0035932 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.1 | 0.3 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 0.5 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.3 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 1.5 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.1 | 0.5 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 1.1 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.3 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.1 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
0.1 | 0.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.1 | 1.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 2.5 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.1 | 0.7 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
0.1 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.1 | 0.4 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.1 | 0.1 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.1 | 0.3 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.1 | 0.3 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 1.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.4 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.1 | 6.8 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) |
0.1 | 0.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.2 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.1 | 0.9 | GO:0006554 | lysine catabolic process(GO:0006554) |
0.1 | 0.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.3 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.3 | GO:0060600 | dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
0.1 | 0.3 | GO:1902590 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
0.1 | 0.3 | GO:0070845 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.1 | 0.5 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 0.1 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.1 | 0.1 | GO:0009644 | response to high light intensity(GO:0009644) |
0.1 | 0.7 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.3 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 0.3 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.1 | 0.7 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.6 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.1 | 0.3 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.1 | 0.2 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
0.1 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 0.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.9 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
0.1 | 0.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 1.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.3 | GO:0018277 | protein deamination(GO:0018277) |
0.1 | 0.2 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.1 | 0.5 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.4 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.1 | 0.2 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
0.1 | 2.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.3 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.1 | 1.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.1 | 0.3 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.5 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.1 | 0.8 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
0.1 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.8 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 1.1 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.1 | 0.2 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.1 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.1 | 0.2 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.1 | 0.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 0.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.1 | 0.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.9 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.2 | GO:2001303 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.1 | 0.2 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.2 | GO:1902728 | positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.1 | 0.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.1 | 0.3 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.1 | 0.6 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.1 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 1.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.3 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.1 | 0.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.1 | 0.6 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.1 | 0.2 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.1 | 0.2 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.1 | 0.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.1 | 0.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.2 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.2 | GO:0003335 | corneocyte development(GO:0003335) |
0.1 | 0.4 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 5.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.3 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) positive regulation of metalloendopeptidase activity(GO:1904685) |
0.1 | 4.7 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 1.1 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.1 | 0.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
0.1 | 0.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.1 | GO:0019374 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.1 | 0.1 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
0.1 | 0.3 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 2.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.2 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.1 | 0.2 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 0.8 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 1.6 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.1 | 0.4 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.1 | GO:1903567 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
0.0 | 0.1 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.0 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.0 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 2.6 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.2 | GO:0044108 | calcitriol biosynthetic process from calciol(GO:0036378) cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
0.0 | 0.1 | GO:0010637 | regulation of mitochondrial fusion(GO:0010635) negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.2 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
0.0 | 0.1 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.0 | 0.6 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.0 | 0.9 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.0 | 0.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.7 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 3.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.6 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 1.9 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.0 | 0.2 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.0 | 1.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 2.5 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.6 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.0 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.0 | 0.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.0 | 0.6 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.4 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.1 | GO:0044691 | tooth eruption(GO:0044691) |
0.0 | 0.4 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) |
0.0 | 0.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.0 | 0.1 | GO:0071332 | positive regulation of vascular wound healing(GO:0035470) epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) cellular response to fructose stimulus(GO:0071332) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) regulation of lactation(GO:1903487) positive regulation of lactation(GO:1903489) |
0.0 | 0.4 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
0.0 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.0 | 0.4 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.1 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 0.9 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.0 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.4 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.0 | 0.9 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.1 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.2 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.0 | 0.8 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.0 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.0 | 0.1 | GO:1904586 | response to putrescine(GO:1904585) cellular response to putrescine(GO:1904586) hepatocyte dedifferentiation(GO:1990828) |
0.0 | 0.2 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.0 | 0.1 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.0 | 0.8 | GO:0007625 | grooming behavior(GO:0007625) |
0.0 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.2 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.0 | 3.2 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.5 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.3 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.2 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.0 | 0.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.3 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.1 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.0 | 3.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) kidney mesenchymal cell proliferation(GO:0072135) metanephric mesenchymal cell proliferation involved in metanephros development(GO:0072136) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.0 | 0.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.1 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 1.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.0 | 0.1 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric DCT cell differentiation(GO:0072240) metanephric nephron tubule formation(GO:0072289) |
0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.0 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0001708 | cell fate specification(GO:0001708) |
0.0 | 0.3 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.8 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.0 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.0 | 0.1 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.0 | 0.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.8 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.0 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.1 | GO:1904530 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
0.0 | 0.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.0 | 0.1 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.0 | 0.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 1.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.1 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.0 | 0.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.0 | 0.1 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.0 | 0.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.4 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 1.0 | GO:0046856 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 1.0 | GO:0051298 | centrosome duplication(GO:0051298) |
0.0 | 0.3 | GO:0001964 | startle response(GO:0001964) |
0.0 | 2.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.1 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.0 | 4.3 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.0 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.3 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.3 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.0 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.0 | 0.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.0 | 0.1 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.0 | 0.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.2 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.0 | 0.1 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.0 | 0.1 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.0 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.2 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.0 | 0.0 | GO:0051495 | positive regulation of cytoskeleton organization(GO:0051495) |
0.0 | 0.2 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) |
0.0 | 0.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.4 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.1 | GO:0099624 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.0 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:0098581 | detection of external biotic stimulus(GO:0098581) |
0.0 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.0 | 0.5 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) |
0.0 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.0 | 0.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.1 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.0 | 0.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.0 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.0 | 0.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.0 | 0.3 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.0 | 0.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.5 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.1 | GO:1902993 | positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.0 | 0.1 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.0 | 0.8 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.0 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
0.0 | 0.1 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.9 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 1.0 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.2 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.0 | 0.6 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 1.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.4 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.0 | 0.0 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.1 | GO:0071529 | cementum mineralization(GO:0071529) |
0.0 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.1 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.0 | 0.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.4 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.1 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.1 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.0 | 0.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.0 | 1.6 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.2 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.0 | 0.1 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.1 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.0 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.1 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.0 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.0 | GO:0051195 | negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.0 | 0.1 | GO:0021772 | olfactory bulb development(GO:0021772) |
0.0 | 0.1 | GO:0030047 | actin modification(GO:0030047) |
0.0 | 0.1 | GO:0032610 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.0 | 0.1 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.0 | 0.3 | GO:0014904 | myotube cell development(GO:0014904) |
0.0 | 0.3 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.0 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.2 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.0 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.5 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.3 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) |
0.0 | 0.0 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.0 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.1 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.0 | 0.2 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.0 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.0 | 0.0 | GO:0072708 | response to sorbitol(GO:0072708) |
0.0 | 0.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.0 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.0 | 0.4 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.0 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) positive regulation of engulfment of apoptotic cell(GO:1901076) regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
0.0 | 0.0 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.0 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.1 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.0 | 0.0 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.0 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.4 | GO:0043574 | peroxisomal transport(GO:0043574) |
0.0 | 0.1 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) |
0.0 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.0 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.3 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.3 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.1 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.0 | 0.1 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.0 | 0.0 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.1 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.9 | GO:0098855 | HCN channel complex(GO:0098855) |
1.6 | 9.8 | GO:0071797 | LUBAC complex(GO:0071797) |
1.0 | 9.9 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.0 | 1.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.9 | 2.8 | GO:0035101 | FACT complex(GO:0035101) |
0.7 | 2.9 | GO:0031523 | Myb complex(GO:0031523) |
0.6 | 3.2 | GO:0002133 | polycystin complex(GO:0002133) |
0.6 | 2.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.6 | 1.8 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.6 | 1.2 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.6 | 3.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.6 | 1.8 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.5 | 3.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.5 | 2.2 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.5 | 1.6 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.5 | 2.1 | GO:0000811 | GINS complex(GO:0000811) |
0.5 | 2.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 2.0 | GO:0044753 | amphisome(GO:0044753) |
0.5 | 1.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.5 | 4.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.5 | 7.0 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 5.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.5 | 1.8 | GO:1990742 | microvesicle(GO:1990742) |
0.5 | 2.3 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.4 | 13.4 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.4 | 9.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.4 | 2.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.4 | 1.2 | GO:0044609 | DBIRD complex(GO:0044609) |
0.4 | 2.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.4 | 7.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.4 | 1.1 | GO:0034657 | GID complex(GO:0034657) |
0.4 | 3.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.4 | 7.5 | GO:0032059 | bleb(GO:0032059) |
0.4 | 1.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 0.4 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
0.4 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 2.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 2.5 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.4 | 1.4 | GO:0045160 | myosin I complex(GO:0045160) |
0.3 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 2.7 | GO:0097361 | CIA complex(GO:0097361) |
0.3 | 1.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 1.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 1.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.3 | 2.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 1.3 | GO:1990423 | RZZ complex(GO:1990423) |
0.3 | 0.7 | GO:0071817 | MMXD complex(GO:0071817) |
0.3 | 1.0 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.3 | 2.9 | GO:0035976 | AP1 complex(GO:0035976) |
0.3 | 0.7 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.3 | 1.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 1.0 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
0.3 | 1.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.3 | 1.9 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 0.9 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.3 | 1.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 3.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 3.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 1.2 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.3 | 2.4 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 0.9 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.3 | 4.0 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 4.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 3.9 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 2.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 2.5 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.3 | 0.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 0.8 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 1.8 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 10.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 3.0 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 1.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.3 | 4.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 0.8 | GO:0070685 | macropinocytic cup(GO:0070685) |
0.2 | 3.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.2 | 1.7 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 5.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 1.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 0.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 0.9 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.2 | 0.9 | GO:0097196 | Shu complex(GO:0097196) |
0.2 | 2.3 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 0.7 | GO:0032302 | MutSbeta complex(GO:0032302) |
0.2 | 1.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 17.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.2 | 2.4 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.2 | 2.8 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 1.3 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 1.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.2 | 1.0 | GO:0016938 | kinesin I complex(GO:0016938) |
0.2 | 1.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 2.5 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 1.0 | GO:1990031 | pinceau fiber(GO:1990031) |
0.2 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 0.6 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.2 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 3.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 1.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 0.4 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.2 | 4.9 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 1.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.2 | 3.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 2.0 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 0.5 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.2 | 0.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.2 | 0.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 1.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.2 | 1.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 0.7 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.2 | 3.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 0.9 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.2 | 0.9 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.2 | 1.4 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.2 | 2.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 2.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 1.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 2.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.8 | GO:0070701 | mucus layer(GO:0070701) |
0.2 | 1.0 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.2 | 0.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 3.3 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 4.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.2 | 2.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 2.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 1.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.6 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.1 | 0.1 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.1 | 0.9 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 1.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 11.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 1.2 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 1.0 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 0.6 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.1 | 1.1 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 5.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 1.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.4 | GO:0043257 | laminin-8 complex(GO:0043257) |
0.1 | 0.8 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.1 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 0.8 | GO:0032044 | DSIF complex(GO:0032044) |
0.1 | 1.0 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.9 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.9 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.2 | GO:0019034 | viral replication complex(GO:0019034) |
0.1 | 0.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 3.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.5 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.1 | 1.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 2.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.5 | GO:0005712 | chiasma(GO:0005712) |
0.1 | 2.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.5 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.3 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.1 | 13.0 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 2.9 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 1.7 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 1.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 14.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 3.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 1.0 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.1 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 11.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.7 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 1.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 1.7 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 1.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 3.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.2 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.7 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.7 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 3.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 0.4 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.1 | 2.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 2.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.4 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.3 | GO:0034455 | t-UTP complex(GO:0034455) |
0.1 | 1.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 1.0 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 1.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 1.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.5 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.1 | 0.3 | GO:0031905 | early endosome lumen(GO:0031905) |
0.1 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.3 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 1.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.8 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 1.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.4 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.1 | 0.3 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.1 | 1.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 1.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.7 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.5 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.1 | 0.9 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 2.0 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 2.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 1.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.3 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 7.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 1.1 | GO:0097433 | dense body(GO:0097433) |
0.1 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 3.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 2.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.1 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 2.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.6 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.2 | GO:0009346 | citrate lyase complex(GO:0009346) |
0.1 | 0.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 0.1 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.1 | 3.8 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 2.3 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.3 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.1 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 1.5 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 5.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 1.0 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.5 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.6 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 9.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 2.1 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.8 | GO:0031672 | A band(GO:0031672) |
0.0 | 1.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.1 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.0 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 3.3 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 1.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 2.5 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.0 | 1.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.0 | 1.0 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 4.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 33.3 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.0 | 1.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 2.0 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.7 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 1.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 1.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 17.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 1.4 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 0.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 2.4 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 2.3 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.0 | 0.1 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.0 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 1.5 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 1.3 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 1.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 1.0 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 1.8 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 3.1 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.0 | 0.3 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.9 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 2.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 1.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 1.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 1.7 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 1.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 4.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.7 | GO:0072372 | nonmotile primary cilium(GO:0031513) primary cilium(GO:0072372) |
0.0 | 0.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.0 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.2 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.0 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.0 | 0.3 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) |
0.0 | 6.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 3.6 | GO:0005635 | nuclear envelope(GO:0005635) |
0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 1.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.1 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
0.0 | 0.3 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 74.7 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.0 | 0.3 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.0 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.0 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.0 | GO:1990635 | proximal dendrite(GO:1990635) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
2.7 | 8.0 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
2.5 | 9.8 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
1.8 | 1.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
1.7 | 5.0 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
1.5 | 7.4 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
1.4 | 4.2 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
1.3 | 6.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
1.2 | 4.9 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
1.1 | 4.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.1 | 3.2 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
1.0 | 2.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.0 | 3.0 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
1.0 | 4.9 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
1.0 | 2.9 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
1.0 | 5.8 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
1.0 | 3.9 | GO:0004335 | galactokinase activity(GO:0004335) |
1.0 | 2.9 | GO:0016731 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
0.9 | 2.8 | GO:0016826 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
0.8 | 2.5 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
0.8 | 4.0 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.8 | 0.8 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
0.8 | 2.3 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.7 | 2.2 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
0.7 | 2.2 | GO:0015067 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
0.7 | 2.2 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.7 | 2.2 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
0.7 | 2.1 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.7 | 2.7 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.7 | 5.3 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.7 | 1.3 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.7 | 3.3 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.6 | 3.2 | GO:0038025 | reelin receptor activity(GO:0038025) |
0.6 | 1.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.6 | 0.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.6 | 7.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.6 | 1.9 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
0.6 | 1.8 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
0.6 | 3.6 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.6 | 2.4 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.6 | 1.8 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.6 | 1.7 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.6 | 1.7 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.6 | 3.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.6 | 1.7 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.5 | 2.7 | GO:0070905 | serine binding(GO:0070905) |
0.5 | 1.6 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
0.5 | 5.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.5 | 4.8 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.5 | 2.7 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
0.5 | 2.1 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.5 | 2.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.5 | 2.6 | GO:0005289 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
0.5 | 1.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.5 | 1.5 | GO:0003774 | motor activity(GO:0003774) |
0.5 | 1.5 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
0.5 | 1.5 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
0.5 | 2.9 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
0.5 | 0.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.5 | 6.7 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.5 | 4.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.5 | 1.8 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
0.5 | 2.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.5 | 1.4 | GO:0033961 | cis-stilbene-oxide hydrolase activity(GO:0033961) |
0.4 | 0.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.4 | 1.8 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.4 | 0.9 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.4 | 0.9 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.4 | 2.2 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.4 | 2.2 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.4 | 3.1 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.4 | 1.3 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.4 | 3.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.4 | 2.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.4 | 1.7 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.4 | 1.3 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
0.4 | 1.7 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.4 | 1.3 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.4 | 2.1 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
0.4 | 1.7 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.4 | 5.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.4 | 12.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 1.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.4 | 2.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.4 | 1.2 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.4 | 0.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.4 | 4.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 2.0 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.4 | 1.2 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
0.4 | 0.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.4 | 5.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.4 | 1.1 | GO:0045142 | triplex DNA binding(GO:0045142) |
0.4 | 1.1 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.4 | 2.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.4 | 1.1 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.4 | 1.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.4 | 1.5 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
0.4 | 1.1 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) |
0.4 | 1.1 | GO:0005055 | laminin receptor activity(GO:0005055) |
0.4 | 0.4 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.4 | 1.8 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.4 | 2.1 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.4 | 2.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 0.3 | GO:0008483 | transaminase activity(GO:0008483) transferase activity, transferring nitrogenous groups(GO:0016769) |
0.3 | 1.0 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.3 | 1.0 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
0.3 | 1.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 3.4 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 2.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 1.0 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.3 | 2.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 2.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 2.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.3 | 1.0 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
0.3 | 1.6 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.3 | 0.3 | GO:0019808 | polyamine binding(GO:0019808) |
0.3 | 6.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 1.6 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.3 | 4.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 1.3 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.3 | 0.9 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.3 | 2.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.3 | 0.9 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.3 | 0.3 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) nucleotide kinase activity(GO:0019201) |
0.3 | 1.2 | GO:0070025 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
0.3 | 4.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 2.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 1.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 1.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 0.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 4.5 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.3 | 1.2 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.3 | 2.1 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.3 | 1.2 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.3 | 1.2 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.3 | 0.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.3 | 0.9 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
0.3 | 2.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 0.9 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.3 | 1.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.3 | 1.1 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
0.3 | 0.9 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
0.3 | 0.9 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.3 | 0.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.3 | 1.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 1.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 3.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.3 | 1.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.3 | 0.8 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 0.8 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.3 | 2.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 0.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 0.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 0.8 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 2.4 | GO:0032810 | sterol response element binding(GO:0032810) |
0.3 | 2.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.3 | 5.6 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 1.8 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.3 | 1.0 | GO:0004803 | transposase activity(GO:0004803) |
0.2 | 1.7 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.2 | 1.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 1.0 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 0.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 0.5 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 4.9 | GO:0008061 | chitin binding(GO:0008061) |
0.2 | 0.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 1.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 1.0 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 2.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 1.2 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.2 | 2.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.2 | 2.8 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.2 | 2.1 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.2 | 12.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 2.4 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.2 | 1.4 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.2 | 1.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.2 | 1.4 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.2 | 0.9 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 0.7 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.2 | 0.9 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
0.2 | 4.4 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 3.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 2.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 1.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.2 | 0.9 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.2 | 2.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 0.7 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 1.1 | GO:0031208 | POZ domain binding(GO:0031208) |
0.2 | 2.2 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 1.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 2.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.7 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.2 | 2.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 4.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 0.4 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.2 | 0.9 | GO:0047708 | biotinidase activity(GO:0047708) |
0.2 | 1.1 | GO:0010736 | serum response element binding(GO:0010736) |
0.2 | 2.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.7 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
0.2 | 0.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 0.9 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 1.7 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.2 | 0.9 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.2 | 0.9 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.2 | 0.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.2 | 1.1 | GO:0004672 | protein kinase activity(GO:0004672) |
0.2 | 1.1 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.2 | 0.6 | GO:0051908 | double-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0051908) |
0.2 | 0.6 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.2 | 1.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.2 | 0.8 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.2 | 0.6 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 6.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 5.1 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.2 | 1.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.2 | 2.0 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.2 | 3.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.8 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 1.0 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.2 | 0.8 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.2 | 0.6 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.2 | 6.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 1.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 2.5 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 0.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 2.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 1.3 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.2 | 1.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 5.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 1.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 1.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 0.2 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.2 | 0.5 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 1.6 | GO:0016889 | crossover junction endodeoxyribonuclease activity(GO:0008821) endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 0.4 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.2 | 1.8 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
0.2 | 3.2 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 0.9 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 1.6 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.2 | 1.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.2 | 2.8 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.2 | 0.9 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.2 | 4.9 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 1.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.5 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
0.2 | 7.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 3.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 1.0 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 0.7 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 0.5 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.2 | 0.7 | GO:0052827 | inositol pentakisphosphate phosphatase activity(GO:0052827) |
0.2 | 1.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 1.4 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.9 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.2 | 1.2 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.2 | 1.4 | GO:0035276 | ethanol binding(GO:0035276) |
0.2 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.5 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.2 | 0.7 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 1.0 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.5 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
0.2 | 0.5 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.2 | 2.4 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.2 | 0.3 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
0.2 | 7.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 1.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.2 | 6.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 1.5 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 1.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 1.3 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 3.6 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 2.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.8 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 2.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 2.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 1.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 1.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 3.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.6 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.2 | 1.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 0.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 1.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.6 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.2 | 2.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 4.8 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.9 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.2 | 0.6 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.2 | 1.2 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.2 | 0.5 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.2 | 1.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 0.5 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.2 | 1.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 0.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.7 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
0.1 | 1.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.4 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 0.3 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 1.6 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 1.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 1.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.4 | GO:0097689 | iron channel activity(GO:0097689) |
0.1 | 0.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 3.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 2.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 2.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.3 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.1 | 0.4 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.1 | 1.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 1.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 7.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 1.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 1.3 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 0.6 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.4 | GO:0080122 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.1 | 1.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 1.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.1 | 0.4 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 1.2 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
0.1 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.5 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.1 | 0.9 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.4 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 1.5 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 1.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.4 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 0.1 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.1 | 1.6 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.5 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.1 | 0.1 | GO:0016829 | lyase activity(GO:0016829) |
0.1 | 0.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.5 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.1 | 0.4 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.5 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.1 | 0.1 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.1 | 1.0 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 0.5 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
0.1 | 1.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 3.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 1.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.5 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
0.1 | 0.4 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.7 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.4 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.7 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.1 | 4.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 2.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 8.9 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 2.7 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 1.7 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 1.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.7 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 1.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 6.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.7 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.1 | 1.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.1 | 1.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 2.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 4.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.3 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
0.1 | 1.8 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.8 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 2.7 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 0.8 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.6 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.1 | 0.4 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.1 | 0.6 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.5 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 1.9 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.3 | GO:0090541 | MIT domain binding(GO:0090541) |
0.1 | 0.2 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 2.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 0.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.4 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.1 | 1.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 1.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.3 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.7 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.2 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
0.1 | 0.6 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.1 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.1 | 1.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 1.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 1.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.6 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.1 | 4.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 1.0 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.1 | 0.3 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.1 | 23.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.7 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 2.0 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 0.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.4 | GO:0004057 | arginyltransferase activity(GO:0004057) |
0.1 | 1.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.7 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 2.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.6 | GO:0046979 | TAP2 binding(GO:0046979) |
0.1 | 0.3 | GO:0004794 | L-serine ammonia-lyase activity(GO:0003941) L-threonine ammonia-lyase activity(GO:0004794) |
0.1 | 0.8 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 1.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.3 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 1.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 1.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 1.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.2 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
0.1 | 0.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 3.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 1.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.7 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 1.4 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.1 | 0.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 2.0 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.2 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.2 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.2 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 1.7 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 1.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 0.8 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.1 | 0.3 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.1 | 0.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.5 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.3 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.1 | 0.5 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 0.4 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 1.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.3 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.1 | 3.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.6 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 2.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 2.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 1.1 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.1 | 0.4 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.1 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.4 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.1 | 0.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 1.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.1 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 1.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 5.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 2.4 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.1 | 0.2 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.1 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 1.0 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 2.2 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.9 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 0.6 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 3.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 0.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 1.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.2 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.1 | 1.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.2 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.1 | 0.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.3 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
0.1 | 2.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.1 | 0.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 2.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.6 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.2 | GO:0008892 | guanine deaminase activity(GO:0008892) |
0.1 | 0.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 1.7 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.3 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) |
0.1 | 1.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.1 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
0.1 | 9.4 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.6 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 0.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.4 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.2 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 1.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.2 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.3 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.1 | 0.4 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 1.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 1.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 1.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.2 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.0 | 0.6 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.2 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.2 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.0 | 0.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.0 | 0.6 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 0.3 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.3 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 0.8 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 1.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 2.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.3 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.0 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 1.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.0 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.0 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
0.0 | 0.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 1.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 1.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.2 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.0 | 0.1 | GO:0046977 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
0.0 | 0.1 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.4 | GO:0035877 | death effector domain binding(GO:0035877) |
0.0 | 0.1 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.0 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.2 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.0 | 0.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.3 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
0.0 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.0 | 0.6 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.0 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.2 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
0.0 | 0.1 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.0 | 0.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.1 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.0 | 0.2 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.0 | 0.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.1 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
0.0 | 0.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 0.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 2.1 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.1 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 1.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 2.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.2 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 3.0 | GO:0015399 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) |
0.0 | 0.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 1.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.0 | 0.1 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.0 | 0.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.2 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.0 | 0.2 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.8 | GO:0005231 | excitatory extracellular ligand-gated ion channel activity(GO:0005231) |
0.0 | 0.9 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 1.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.1 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.0 | 0.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 1.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.0 | 0.6 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.1 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.0 | 0.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.0 | 0.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 1.1 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.1 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 0.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.1 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.0 | 0.2 | GO:0016247 | channel regulator activity(GO:0016247) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.0 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.1 | GO:0016301 | kinase activity(GO:0016301) |
0.0 | 0.0 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
0.0 | 0.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.0 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.0 | 0.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.0 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.0 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 3.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 1.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 1.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 14.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 12.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.2 | 4.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 4.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 8.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 4.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 9.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 5.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 9.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 2.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 7.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 3.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 4.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 2.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.8 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 3.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 2.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 1.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 4.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 1.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 2.7 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 2.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 1.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 2.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 2.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.8 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 2.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 2.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 1.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 2.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.5 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 1.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 2.7 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.6 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 2.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.1 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 1.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 2.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 2.4 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 0.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.7 | 3.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.6 | 10.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.6 | 5.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.5 | 0.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.4 | 13.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.4 | 8.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 2.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.4 | 5.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 7.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 4.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.3 | 3.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 9.1 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.3 | 1.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 7.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 7.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 19.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 8.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 2.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.2 | 8.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 3.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 0.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 4.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 15.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 3.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 6.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 3.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 5.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 1.6 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.2 | 5.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 0.7 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.2 | 7.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 3.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 7.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 4.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 6.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 2.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 5.7 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 6.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 5.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 4.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 2.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 3.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 2.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 3.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 9.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 5.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 1.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 5.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 4.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 10.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 3.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 5.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 4.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.6 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.1 | 0.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 3.4 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 1.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.3 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.1 | 14.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 4.3 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.1 | 0.6 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 6.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 3.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 2.9 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 0.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 3.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 2.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 10.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 5.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.6 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 2.9 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.8 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.1 | 1.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 2.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 2.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 4.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 3.3 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 1.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 2.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 4.1 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 1.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 2.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.3 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 1.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 2.6 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 3.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 2.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.8 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 0.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.3 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 2.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 1.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 3.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 1.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 1.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 3.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 3.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 0.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 1.8 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 1.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 7.3 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.0 | 0.3 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.0 | 1.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 1.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 1.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 2.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.0 | 0.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 2.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 2.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 3.0 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.8 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 1.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 2.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 0.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 2.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.1 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |